Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts $5.98 +0.20 (+3.46%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$5.98 -0.01 (-0.08%) As of 10/24/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vir Biotechnology Earnings Summary Vir Biotechnology released Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.80, which missed the consensus estimate of -$0.72 by $0.08. Quarterly revenue fell 60.5% year-over-year to $1.21 million, below analyst estimates of $2.38 million. With a trailing EPS of -$4.00, Vir Biotechnology's earnings are expected to grow next year, from ($3.92) to ($3.55) per share. Upcoming Q3 Earnings DateNov. 5After Market ClosesConfirmedConsensus EPS (Aug. 6) -$0.72 Actual EPS (Aug. 6) -$0.80 Missed By -$0.08 Actual Revenue (Aug. 6) $1.21MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)VIR Upcoming EarningsVir Biotechnology's Q3 2025 earnings is scheduled for Wednesday, November 5, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Vir Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vir Biotechnology and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataVIR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VIR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vir Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.09-$0.68-$0.89Q2 20252-$0.95-$0.54-$0.75Q3 20252-$0.88-$0.54-$0.71Q4 20252-$0.62-$0.53-$0.58 FY 2025 8 -$3.54 -$2.29 -$2.92 Q1 20261-$0.53-$0.53-$0.53Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.57-$0.57-$0.57Q4 20261-$0.58-$0.58-$0.58 Vir Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Confirmed)-------8/6/2025Q2 2025-$0.72-$0.80 -$0.08-$0.80$2.38M$1.21M5/7/2025Q1 2025-$0.83-$0.88 -$0.05-$0.88$8.59M$3.03M2/26/2025Q4 2024-$0.85-$0.76+$0.09-$0.76$8.14M$12.37M10/31/2024Q3 2024-$1.05-$1.56 -$0.51-$1.56$5.54M$2.38M8/1/2024Q2 2024-$0.89-$1.02 -$0.13-$1.02$7.53M$3.08M5/2/2024Q1 2024-$0.99-$0.48+$0.51-$0.48$11.71M$56.38M2/22/2024Q4 2023-$1.14-$0.86+$0.28-$0.86$11.18M$16.80M11/2/2023Q3 2023-$1.21-$1.22 -$0.01-$1.22$12.57M$2.64M Vir Biotechnology Earnings - Frequently Asked Questions When is Vir Biotechnology's earnings date? Vir Biotechnology has confirmed that its next quarterly earnings data will be published on Wednesday, November 5th, 2025. Learn more on VIR's earnings history. Did Vir Biotechnology beat their earnings estimates last quarter? In the previous quarter, Vir Biotechnology (NASDAQ:VIR) missed the analysts' consensus estimate of ($0.72) by $0.08 with a reported earnings per share (EPS) of ($0.80). Learn more on analysts' earnings estimate vs. VIR's actual earnings. How can I listen to Vir Biotechnology's earnings conference call? The conference call for Vir Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Vir Biotechnology's conference call transcript? The conference call transcript for Vir Biotechnology's latest earnings report can be read online. Read Transcript How much revenue does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded annual revenue of $74.21 million. How much profit does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded net income of -$521.96 million. VIR has generated -$4.00 earnings per share over the last four quarters. What is Vir Biotechnology's EPS forecast for next year? Vir Biotechnology's earnings are expected to grow from ($3.92) per share to ($3.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies XENE Earnings Results QURE Earnings Results ZLAB Earnings Results CGON Earnings Results RARE Earnings Results IRON Earnings Results AMRX Earnings Results APLS Earnings Results CNTA Earnings Results TARS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Freeport-McMoRan Posts Strong Earnings Despite Indonesia ShutdownTesla’s Earnings Review: Does the Juice Justify the Squeeze?Fal.Con Europe Could Be CrowdStrike’s Early Earnings CatalystLogitech Eyes Breakout Before Earnings—Citigroup Sees 30% UpsideLouis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings This page (NASDAQ:VIR) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
